Hims & Hers is a direct-to-consumer telehealth and pharmacy platform focused on common, stigmatized health conditions including hair loss, erectile dysfunction, anxiety, birth control, and weight management. The company acquires customers through heavy digital advertising and connects them to telehealth consultations and prescription medications delivered by mail. It went public via SPAC in January 2021 and has expanded rapidly into GLP-1 weight loss medications.
IPO details
IPO date
Wed Jan 20
IPO price
—
First-day close
—
IPO valuation
$8.45B
Market-data summary
Current price
—
Market cap
—
Day range
—
52-week range
—
Data last checked Sat Oct 03. Optional market data is not yet available where shown as —.